J. Mateo

发表

Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk

D. Corella, A. Estellés, C. Falcó, 2003, Thrombosis and Haemostasis.

Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia.

L. Almasy, L. Almasy, J. Blangero, 2000, American journal of human genetics.

Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications.

J. Fontcuberta, M. Sabater-Lleal, J. Soria, 2003, Haematologica.

Management of Anticoagulation in Patients Who Requiere Colonoscopy or Gastroscopy: Safety and Efficacy of Sodic Bemiparin (Hibor®.

J. Fontcuberta, J. Souto, J. Mateo, 2004 .

Low‐molecular‐weight heparin as bridging therapy during interruption of oral anticoagulation in patients undergoing colonoscopy or gastroscopy

J. Fontcuberta, J. Mateo, A. Santamaría, 2007, International journal of clinical practice.

Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study).

J. Fontcuberta, J. Mateo, N. Sala, 1998, Blood Coagulation and Fibrinolysis.

The Prothrombin 20210A Allele Is the Most Prevalent Genetic Risk Factor for Venous Thromboembolism in the Spanish Population

J. Fontcuberta, J. Souto, J. Mateo, 1998, Thrombosis and Haemostasis.

Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene.

J. Fontcuberta, J. Souto, J. Soria, 2001, Haematologica.

Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.

J. Fontcuberta, J. Souto, J. Soria, 2001, Haematologica.

D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain.

A. Bayés‐Genís, R. Schwartz, J. Guindo, 2000, American heart journal.

Pulmonary Thrombosis or Embolism in a Large Cohort of Hospitalized Patients With Covid-19

J. Mateo, I. Castellví, J. Casademont, 2020, Frontiers in Medicine.

Old and New Anticoagulant Agents for the Prevention and Treatment of Patients with Ischemic Stroke

J. Martí-Fàbregas, J. Mateo, 2009, Cerebrovascular Diseases.

Intracerebral haemorrhage in anticoagulated patients, What do we do afterwards?

R. Delgado-Mederos, J. Martí-Fàbregas, J. Mateo, 2012 .

Tromboc@t Working Group recommendations for management in patients receiving direct oral anticoagulants

G. Perea, J. Mateo, Á. Moya, 2018, Medicina Clínica (English Edition).

Methylene blue‐photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study

J. Mateo, Arturo Pereira, J. de la Rubia, 2008, British journal of haematology.

Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines—A Multidisciplinary (SEMI–SEOM–SETH) Expert Consensus

E. Gallardo, J. González-Porras, P. Pérez-Segura, 2018, TH Open.

Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study.

J. Fontcuberta, J. Mateo, E. Muñiz‐Díaz, 1995, The Journal of thoracic and cardiovascular surgery.

Patients with thrombocytosis have normal or slightly elevated thrombopoietin levels.

J. Mateo, I. Español, N. Pujol-Moix, 1999, Haematologica.

Elevated Levels of Plasmin-α2 Antiplasmin Complexes in Unstable Angina

A. Bayés‐Genís, A. Bayés de Luna, J. Guindo, 1999, Thrombosis and Haemostasis.

Diagnosis and management of von willebrand disease in Spain

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2018 .

The c.1787G>T and c.1787G>A Mutations are not Found in the Prothrombin Gene in a Spanish Population

J. Fontcuberta, J. Souto, J. Mateo, 2017 .

Thromboplastin-thrombomodulin-mediated time: a new global test sensitive to protein S deficiency and increased levels of factors II, V, VII and X.

J. Fontcuberta, J. Mateo, M. Borrell, 2002, Haematologica.

Association after linkage analysis indicates that homozygosity for the 46C→T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis

J. Fontcuberta, J. Souto, J. Soria, 2004, Thrombosis and Haemostasis.

Risk of Ischemic Stroke Associated With Functional Thrombin-Activatable Fibrinolysis Inhibitor Plasma Levels

J. Martí-Fàbregas, J. Fontcuberta, J. Souto, 2003, Stroke.

Multilocus Genetic Risk Scores for Venous Thromboembolism Risk Assessment

D. Trégouët, P. Morange, J. Vila, 2014, Journal of the American Heart Association.

Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH–SETH

J. González-Porras, J. Mateo, R. Lecumberri, 2021, Clinical and Translational Oncology.

The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism

J. Fontcuberta, J. Soria, J. Mateo, 2005, Thrombosis and Haemostasis.

Laboratory Evaluation and Clinical Characteristics of 2,132 Consecutive Unselected Patients with Venous Thromboembolism – Results of the Spanish Multicentric Study on Thrombophilia (EMET*-Study)

J. Fontcuberta, J. Mateo, N. Sala, 1997, Thrombosis and Haemostasis.

Successful suppression using Rituximab of a factor VIII inhibitor in a boy with severe congenital haemophilia: An example of a significant decrease of treatment costs

E. Tizzano, J. Fontcuberta, J. Mateo, 2006, Thrombosis and Haemostasis.

Homozygosity of the T allele of the 46 C-->T polymorphism in the F12 gene is a risk factor for acute coronary artery disease in the Spanish population.

J. Fontcuberta, J. Soria, J. Mateo, 2004, Haematologica.

[Limitations of anticoagulant therapy].

R. Delgado-Mederos, J. Martí-Fàbregas, J. Mateo, 2012, Neurologia.

Platelet hyperaggregability and venous thrombosis risk: results from the RETROVE project.

J. Fontcuberta, J. Souto, J. Mateo, 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Moderate hyperhomocysteinemia is a highly prevalent defect in Spanish patients with venous thromboembolic disease.

J. Souto, J. Mateo, F. Blanco-Vaca, 1998, Haematologica.

VAMP8 and serotonin transporter levels are associated with venous thrombosis risk in a Spanish female population. Results from the RETROVE Project.

J. Fontcuberta, J. Souto, J. Mateo, 2019, Thrombosis research.

IgM anti-protein S antibodies as a risk factor for venous thrombosis

J. Fontcuberta, J. Mateo, A. Santamaría, 2008, Haematologica.

Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease

J. Fontcuberta, J. Mateo, J. Souto, 1995, Digestive Diseases and Sciences.

Lack of association between venous thrombosis and subsequent malignancy in a retrospective cohort study in young patients

J. Fontcuberta, J. Souto, J. Mateo, 1999, American journal of hematology.

Short closure time values in PFA-100® are related to venous thrombotic risk. Results from the RETROVE Study.

J. Fontcuberta, J. Souto, J. Soria, 2018, Thrombosis Research.

The Relationship between Leukocyte Counts and Venous Thromboembolism: Results from RETROVE Study

J. Souto, J. Soria, J. Mateo, 2017 .

Association of functional thrombin‐activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population

J. Fontcuberta, J. Souto, J. Mateo, 2004, American journal of hematology.

Postprandial thrombin activatable fibrinolysis inhibitor and markers of endothelial dysfunction in type 2 diabetic patients.

A. de Leiva, M. Rigla, A. Wägner, 2006, Metabolism: clinical and experimental.

Short-course thrombolysis as the first line of therapy for cardiac valve thrombosis.

F. Carreras, J. Fontcuberta, J. Souto, 1998, The Journal of thoracic and cardiovascular surgery.

Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT)

J. González-Porras, J. Paramo, J. Mateo, 2022, Medicina Clínica (English Edition).

Low levels of plasminogen activator inhibitor type 1 in patients with inflammatory bowel disease

J. Fontcuberta, J. Mateo, J. Souto, 1994 .

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2018, PloS one.

The V617F mutation of JAK2 is very uncommon in patients with thrombosis.

J. Fontcuberta, J. Mateo, Á. Remacha, 2007, Haematologica.

Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level.

J. Fontcuberta, J. Mateo, A. Martínez-Rubio, 2004, Haematologica.

Activated protein C resistance assay when applied in the general population.

J. Souto, J. Mateo, M. Borrell, 1997, American journal of obstetrics and gynecology.

ADAMTS‐13 activity and von Willebrand factor levels in methylene blue photo‐inactivated plasma processed by either the Springe method or an ‘in house’ system

J. Mateo, A. Álvarez-Larrán, J. Arroyo, 2008, Vox sanguinis.

Low ADAMTS13 levels are associated with venous thrombosis risk in women.

J. Fontcuberta, J. Souto, J. Mateo, 2017, Thrombosis research.

Platelet function during cardiopulmonary bypass not changed by two different doses of aprotinin.

J. Fontcuberta, J. Souto, J. Mateo, 2000, Haematologica.

Molecular and clinical profile of von Willebrand disease in Spain (PCM–EVW–ES): Proposal for a new diagnostic paradigm

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2015, Thrombosis and Haemostasis.

Rapid identification of female haemophilia A carriers with deletions in the factor VIII gene by quantitative Real-Time PCR analysis

M. Barceló, M. Baiget, E. Tizzano, 2005, Thrombosis and Haemostasis.

The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.

J. Fontcuberta, J. Souto, J. Mateo, 2000, Haematologica.

Homozygosity of the T Allele of the 46 C→T Polymorphism in the F12 Gene Is a Risk Factor for Ischemic Stroke in the Spanish Population

J. Martí-Fàbregas, J. Fontcuberta, J. Souto, 2004, Stroke.

Thrombolysis as the first line of therapy for cardiac valve thrombosis.

J. Fontcuberta, J. Souto, J. Mateo, 1993, Circulation.

Low levels of tissue factor pathway inhibitor (TFPI) in two out of three members of a family with thrombophilia.

J. Fontcuberta, J. Mateo, M. Borrell, 1995, Thrombosis research.

The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis

J. Mateo, T. Martín Lorenzo, B. Gil, 2022, BMC Health Services Research.

Severe bleeding in a patient with spontaneous factor VIII inhibitor and acute exacerbation of chronic pancreatitis

J. Fontcuberta, J. Mateo, C. Martinez, 1996, Intensive Care Medicine.

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2017, Haematologica.

Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time.

L. Almasy, J. Blangero, J. Fontcuberta, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2020, Thrombosis and Haemostasis.

Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis.

L. Almasy, J. Blangero, J. Fontcuberta, 2000, Blood.

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

J. Mateo, A. Berzigotti, J. García‐Pagán, 2017 .

Platelet ultrastructural morphometry for diagnosis of partial delta-storage pool disease in patients with mild platelet dysfunction and/or thrombocytopenia of unknown origin. A study of 24 cases.

G. Escolar, J. Mateo, I. Español, 2000, Haematologica.

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis.

J. González-Porras, J. Corral, V. Vicente, 2007, Blood.

A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility.

L. Almasy, J. Blangero, A. Buil, 2003, Blood.

Higher risk of ischaemic stroke associated with factor XI levels in dyslipidaemic patients

J. Martí-Fàbregas, J. Fontcuberta, J. Mateo, 2007, International journal of clinical practice.

Novel Oral Anticoagulants and Their Role in Clinical Practice

J. Mateo, 2019 .

Platelet count and plateletcrit are associated with an increased risk of venous thrombosis in females. Results from the RETROVE study.

J. Fontcuberta, J. Souto, J. Soria, 2017, Thrombosis research.

Effect of Prophylactic Treatment with Low-Molecular-Weight Heparin Bemiparin Sodium on Serum Potassium Levels

J. Mateo, D. Ruiz, N. Hernández, 2010, Drugs & aging.

Genetic determinants of hemostasis phenotypes in Spanish families.

L. Almasy, J. Blangero, J. Fontcuberta, 2000, Circulation.

Double heterozygosity for Factor V Leiden and Factor V Cambridge mutations associated with low levels of activated protein C resistance in a Spanish thrombophilic family

J. Fontcuberta, J. Mateo, A. Santamaría, 2005, Thrombosis and Haemostasis.

A Quantitative Trait Locus Influencing Free Plasma Protein S Levels on Human Chromosome 1q: Results From the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project

L. Almasy, J. Blangero, M. Lathrop, 2003, Arteriosclerosis, Thrombosis and Vascular Biology.

Homozygotes for prothrombin gene 20210 A allele in a thrombophilic family without clinical manifestations of venous thromboembolism.

J. Fontcuberta, J. Souto, J. Soria, 1999, Haematologica.

Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism

P. Morange, J. Souto, E. Salas, 2015, Applied Health Economics and Health Policy.

Economic Analysis Of Thrombo Incode, A Clinical-Genetic Function For Assessing The Risk Of Venous Thromboembolism.

P. Morange, J. Souto, E. Salas, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Evolution of leukotriene B4, peptide leukotrienes, and interleukin‐8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: Mortality prognostic study

J. Fontcuberta, J. Mancebo, J. Mateo, 2000, Critical care medicine.

Normalisation of Tissue Factor Pathway Inhibitor Activity after Glycaemic Control Optimisation in Type 1 Diabetic Patients

A. de Leiva, M. Rigla, J. Fontcuberta, 2000, Thrombosis and Haemostasis.

Presentation of an acquired factor VIII inhibitor with a muscular haematoma mimicking a deep venous thrombosis in a patient with breast cancer.

J. Fontcuberta, J. Mateo, J. Cruz, 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Carotid thrombosis after in vitro fertilization: a relatively new thrombotic complication in women

J. Fontcuberta, J. Mateo, A. Santamaría, 2008, British journal of haematology.

Type 2N VWD: Conclusions from the Spanish PCM‐EVW‐ES project

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Physical training decreases plasma thrombomodulin in Type I and Type II diabetic patients

A. de Leiva, M. Rigla, J. Fontcuberta, 2001, Diabetologia.

Combined cis-regulator elements as important mechanism affecting FXII plasma levels.

L. Almasy, J. Blangero, J. Fontcuberta, 2010, Thrombosis research.

A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease.

L. Almasy, J. Blangero, A. Buil, 2002, American journal of human genetics.

Patients with venous thromboembolism have a lower APC response than controls. Should this be regarded as a continuous risk factor for venous thrombosis?

J. Fontcuberta, J. Souto, J. Mateo, 1999, Haematologica.

Elevated levels of plasmin-alpha2 antiplasmin complexes in unstable angina.

A. Bayés‐Genís, A. Bayés de Luna, J. Guindo, 1999, Thrombosis and haemostasis.

Correlation between PlateletWorks® and PFA-100® for Measuring Platelet Function before Urgent Surgery in Patients with Chronic Antiplatelet Therapy

M. Martínez-Zapata, J. Mateo, V. Moral, 2021, Journal of clinical medicine.

Hemostatic disturbances in acute ischemic stroke: a study of 86 patients.

J. Fontcuberta, J. Martí-Vilalta, J. Mateo, 1995, Acta haematologica.

Genetic Regulation of Plasma Levels of Vitamin K-dependent Proteins Involved in Hemostasis

L. Almasy, J. Blangero, J. Fontcuberta, 2001, Thrombosis and Haemostasis.

Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2018, Haematologica.

[Pregnancy and thrombophilia in women with congenital deficit of antithrombin III, protein C, protein S or plasminogen: analysis of 39 cases].

J. Fontcuberta, J. Mateo, M. Borrell, 1993, Medicina clínica (Ed. impresa).

What is the clinical impact of low plasminogen activator inhibitor‐1 (PAI‐1) activity? A case report and study of the incidence of low PAI‐1 antigen in a healthy population

J. Fontcuberta, J. Mateo, A. Santamaría, 2007, Journal of thrombosis and haemostasis : JTH.

Recommendations for perioperative antiplatelet treatment in non-cardiac surgery. Working Group of the Spanish Society of Anaesthesiology-Resuscitation and Pain Therapy, Division of Haemostasis, Transfusion Medicine, and Perioperative Fluid Therapy. Update of the Clinical practice guide 2018

J. Mateo, J. Llau, R. Ferrandis, 2019, Revista Española de Anestesiología y Reanimación (English Edition).

Skin Necrosis at the Injection Site Induced by Low-Molecular-Weight Heparin: Case Report and Review

J. Fontcuberta, J. Souto, J. Mateo, 1998, Dermatology.

Lack of Effect of Influenza Vaccine on Anticoagulation by Acenocoumarol

J. Fontcuberta, J. Mateo, A. Sureda, 1993, The Annals of pharmacotherapy.

A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility.

L. Almasy, A. Buil, M. Lathrop, 2003 .

Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis

L. Almasy, J. Blangero, J. Fontcuberta, 2000 .

Hemostasis, Thrombosis, and Vascular Biology Patients and Methods Subjects and Phenotypes Table 1. Results from the Linkage Analysis: Apcr with F5 Dna Variants, and Apcr Conditional on the Fvl Mutation

L. Almasy, J. Blangero, A. Buil, 2022 .

[Detection of thrombin-antithrombin complexes in hypercoagulability conditions. Analysis of 182 cases].

J. Fontcuberta, J. Mateo, M. Borrell, 1990, Sangre.

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

J. Mateo, J. García‐Pagán, J. Genescà, 2017, Gastroenterologia y hepatologia.

Tromboc@t Working Group recommendations for management in patients receiving direct oral anticoagulants.

G. Perea, J. Mateo, Á. Moya, 2018, Medicina clinica.

Acquired factor VIII inhibitor preceding chronic lymphocytic leukemia

J. Fontcuberta, J. Mateo, M. Borrell, 1993, Annals of Hematology.